Not only did the authors demonstrate that the US lagged behind in comparison to other countries, but there was also an age-related discrepancy in amenable mortality *within* the country.[@bib0005] This supports the hypothesis that amenable mortality reductions correlate to healthcare access: those over 65 have universal access to MediCare whilst those under 65 may or may not be covered by personal or employer insurance policies. Overall, both the number of uninsured individuals and the proportion of the population uninsured have increased between 1999 and 2006 in the US, with a slight decline in 2007 ([Figure 1](#fig0005){ref-type="fig"}).[@bib0015] In 2007, 45.7 million Americans were uninsured (approximately 15.3% of the population), thus lacking access to health care.[@bib0015]

However, a previous literature review has demonstrated that there are several problems with using amenable mortality as an indicator. First, there is variability in the definition of 'amenable mortality', making it difficult to compile evidence for this measure.[@bib0020] Some studies that were evaluated used amenable mortality, while others used 'preventable mortality' (deaths preventable through primary care or public health guidelines), or 'avoidable mortality' (a combination of preventable and amenable mortality).[@bib0020] Since there was no standard definition of amenable mortality, it would be difficult to compare the results of different studies.[@bib0020]

Secondly, it has been challenging to assess the impact of a healthcare system on amenable mortality, as several studies show there was weak or no association.[@bib0020] Furthermore, some studies found that socioeconomic and lifestyle variables (i.e. smoking, employment status, etc.) had a larger effect on amenable mortality than the quality of the healthcare system.[@bib0020] Lastly, the authors indicated that healthcare activity and quality variables should be used to define the relationship between the healthcare system and amenable mortality. Their empirical analysis showed that no study they examined used these variables.[@bib0020]

While the authors reviewed the studies, they suggested three important points to consider: (1) *time lag:* interventions may show an effect on mortality, although this may be delayed; (2) *disease incidence*: a decline in mortality, may be due to a actual decline in incidence; (3) *use of healthcare expenditure variable* -- larger expenditure may be correlated with larger mortality rates, but only because more resources are spent on treatment/prevention.[@bib0020]

Moreover, Machenbach *et al.* suggested that high mortality, incidence, and risk factors for the disease *prior* to introduction of an intervention play an important role in concealing the true effect of any new intervention[@bib0025]. Nolte *et al.* illustrates, that the United Kingdom had a larger amenable mortalityTable 1Reduction of Amenable Mortality People Aged 0--74 between 1999--2006/2007[@bib0005]CountryMen (%)Women (%)United Kingdom36.931.9France27.723.4German24.322.7United States18.517.5than Germany in 1999, with both countries declining in amenable mortality in 2007 ([Table 2](#tbl0010){ref-type="table"}).[@bib0005] However, since the UK had a larger initial amenable mortality, this larger decline may be mistakenly interpreted as indicating a better health care system, when it should be attributed to the higher baseline mortality.

Amenable mortality can still be used as a measure for healthcare across nations; however, its limitations must be contemplated. Other measures of healthcare can help enhance the robustness of such results. Considering that, in 2007, the United States performed worse than the other three countries studied in both life expectancy and infant mortality, this would support amenable mortality as a good indicator ([Table 3](#tbl0015){ref-type="table"}).[@bib0030]^,^[@bib0035]

Currently, the US has established the Patient Protection and Affordable Care Act that is intended to reduce the number of uninsured Americans, as well as decrease the costs of healthcare.[@bib0040] Future research assessing its impact on amenable mortality, both in comparison to other countries and within itself, would be of great interest.
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###### 

Age-standardized death rates (per 100,000) for all amenable causes in 1999 to 2006/2007 for men aged 0--64[@bib0005]

  Country          1999    2007
  ---------------- ------- -------
  France           47.25   37.13
  Germany          60.66   49.53
  United Kingdom   72.71   53.01
  United States    78.17   68.81

###### 

Comparison of Life Expectancy and Infant Mortality in 2007[@bib0030]^,^[@bib0035]

  Country          Life Expectancy (years)   Infant Mortality (deaths per 1,000 live births)
  ---------------- ------------------------- -------------------------------------------------
  German           80.0                      3.9
  France           80.9                      3.8
  United Kingdom   79.9                      4.8
  United States    77.9                      6.8
